Orexo sues Sun Pharma over opioid dependence generic
16-09-2020
US states sue 26 drugmakers over alleged price fixing
11-06-2020
44 states accuse big pharma of price fixing generics market
13-05-2019
Pavel Kapysh / Shutterstock.com
A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Generics, Sun Pharma, Taro, Sandoz, price-fixing, antitrust, DoJ, prosecutors, charges, investigation
